Périodique
Provision of hepatitis C education in a nationwide sample of drug treatment programs.
(Prévention de l' hépatite C dans un échantillon national de programmes de traitement de l'usage de drogues aux Etats-Unis)
Auteur(s) :
ASTONE, J. ;
STRAUSS, S. M. ;
VASSILEV Z. P. ;
DES JARLAIS, D. C.
Année :
2003
Page(s) :
107-117
Langue(s) :
Anglais
Refs biblio. :
29
Domaine :
Drogues illicites / Illicit drugs
Discipline :
MAL (Maladies infectieuses / Infectious diseases)
Note générale :
Journal of Drug Education, 2003, 33, (1), 107-117
Note de contenu :
Tab.
Résumé :
ENGLISH :
Hepatitis C virus (HCV) has reached epidemic proportions among drug users, and drug programs are in a unique position to provide each of their patients with HCV education. Using a nationwide sample (N = 434) of drug treatment programs, we report the results of a logistic regression analysis that differentiates programs providing HCV education to all of their patients versus programs that do not. Fifty-four percent of the programs provide HCV education to a 11 of their patients. Programs are about four and a half times as likely to provide HCV education to all patients if they dispense methadone; almost four times as likely to provide this service if they educate most of their staff about HCV; twice as likely if they are residential; and almost twice as likely if they conduct HIV testing on-site. Our findings indicate that there is a need to increase HCV educational services in drug treatment programs. (Author's abstract)
Affiliation :
National Development Research Institutes, 71 West 23rd Street, New York, NY 10010
Etats-Unis. United States.
Etats-Unis. United States.